Google
ALMR 株価分析 — ALAMAR BIOSCIENCES, INC. COMMON STOCK (Healthcare >> Medical Devices)
ALMR に関するよくある質問
ALMRのROE（自己資本利益率）は？
ALAMAR BIOSCIENCES, INC. COMMON STOCKのROEは16.28%です。
ALMRの配当利回りは？
ALAMAR BIOSCIENCES, INC. COMMON STOCKの配当利回りは0.00%です。
ALMRの品質スコア（Quality Score）は？
当社のAIはALMRの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
ALMRは今が買い時ですか？
当社AIのタイミングスコアは100点中67点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
ALMRはどのセクターに属しますか？
ALAMAR BIOSCIENCES, INC. COMMON STOCKはHealthcare >> Medical Devicesセクターに分類されます（NASDAQ市場）
ALMR AI Analysis Summary
Our AI summary for ALMR: ALAMAR BIOSCIENCES, INC. COMMON STOCK (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 0.00, ROE of 16.28%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 67/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 25.36
Price
0.29
(1.16%)
Day Change
|
|
|---|
ALMR, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROAが低い
ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
39% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | N/A |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 25.36 |
| PBV / Sector |
-9.76 / -101.57
|
| Earning Per Share | -0.42 |
| PE / Sector |
N/A / 31.23
|
| PEG or PE/Growth / Sector |
N/A / 0.40
|
| Average 1M Daily Value |
5.68 M
GREAT
|
| Average 1W Daily Value |
4.48 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
37% |
| ポイントになる統計 |
|
64% |
| 配当 |
|
8% |
| 登録情報 |
| Analyze Date | 2026-08-01 07:59:27 |
| Symbol | ALMR |
| Name | ALAMAR BIOSCIENCES, INC. COMMON STOCK |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 69.31 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,737.63 / 20,104.97 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 47071 Bayside Parkway, Fremont, CA, United States, 94538
Phone: (510) 626-9888
Website: https://alamarbio.com
Employees: 222
Sector: Healthcare >> Medical Devices
Description: Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and ultimately, and diagnostics. The company's offering is utilized in research areas including immunology, neurology, and oncology. It serves global research and academic institutions, biopharmaceutical companies, contract research organizations, and service labs. The company operates in the United States, rest of Europe, Middle East and Africa, Germany, Asia Pacific, and internationally. The company was incorporated in 2018 and is based in Fremont, California.
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
